The decline happened because the loss of Rs 2277 crore that the company posted in the March 2022 quarter. This loss happened because of the one-time charge that the company incurred due to payment for legal settlements in United States. Most of this payment was for settling a class- action suit brought against Ranbaxy in United States. Ranbaxy is now a subsidiary of Sun Pharma after the latter acquired it. The class action suit brought by some US citizens alleged that Ranbaxy did fraud to delay the launch by competitors of their own generic medicines in the US market.
After the decline today, Sun Pharma’s stock may see some uptick in the coming days on the back of value buying.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.